Mantle cell lymphoma (MCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the mantle zone of lymphoid follicles. It typically presents with lymphadenopathy, splenomegaly, and bone marrow involvement. The ICD-10 Code C83.18 facilitates accurate diagnosis, documentation, and billing for this condition, ensuring proper treatment and public health reporting.
What is ICD-10 Code C83.18 for Mantle cell lymphoma, lymph nodes of multiple sites?
ICD-10 Code C83.18 represents mantle cell lymphoma affecting lymph nodes at multiple sites. This aggressive form of B-cell lymphoma is associated with specific genetic abnormalities and can lead to significant morbidity. The code is used in clinical documentation and billing when diagnosing patients with this condition, ensuring appropriate treatment and resource allocation.
ICD-10 Code C83.18 – Clinical Definition and Explanation of Mantle cell lymphoma, lymph nodes of multiple sites
Mantle cell lymphoma is caused by the malignant transformation of B-lymphocytes, often linked to chromosomal translocations involving the CCND1 gene. The disease progresses rapidly, necessitating prompt medical intervention to manage symptoms and prevent complications.
Key Clinical Features:
- Painless lymphadenopathy, often in cervical, axillary, or inguinal regions.
- Splenomegaly and hepatomegaly may be present.
- Bone marrow infiltration leading to cytopenias.
- Potential for gastrointestinal involvement, presenting as abdominal pain or obstruction.
ICD-10 Code C83.18 for Mantle cell lymphoma, lymph nodes of multiple sites – SOAP Notes & Clinical Use
ICD-10 Code C83.18 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
What Does ICD-10 Code C83.18 for Mantle cell lymphoma, lymph nodes of multiple sites Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C83.18 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of mantle cell lymphoma. This code supports continuity of care, facilitates billing, and meets EHR documentation standards.
Treatment Options for ICD-10 Code C83.18 – Mantle cell lymphoma, lymph nodes of multiple sites
Prompt treatment for mantle cell lymphoma is critical due to its aggressive nature. Hospitalization may be necessary for intensive therapy.
Antibiotic Therapy:
- Not applicable as mantle cell lymphoma is not an infectious disease.
Supportive Care:
- Chemotherapy regimens such as R-CHOP or R-HyperCVAD.
- Targeted therapies like ibrutinib or acalabrutinib.
- Supportive measures for managing symptoms and side effects.
Infection Control:
- Implement standard precautions to prevent infections during treatment.
- Monitor for febrile neutropenia and initiate prophylactic antibiotics as needed.
How to Document Symptoms of Mantle cell lymphoma, lymph nodes of multiple sites (ICD-10 C83.18) in SOAP Notes
Subjective:
- Patient reports painless swelling in multiple lymph node regions.
- History of unexplained weight loss and night sweats.
- Complaints of fatigue and decreased appetite.
Objective:
- Physical examination reveals enlarged cervical and axillary lymph nodes.
- Splenomegaly noted on abdominal examination.
- Complete blood count shows anemia and thrombocytopenia.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Mantle cell lymphoma, lymph nodes of multiple sites (ICD-10 Code C83.18)
Assessment:
- Diagnosis: Mantle cell lymphoma, lymph nodes of multiple sites, aggressive subtype.
- ICD-10 Code: C83.18.
- Contributing factors: Advanced age, male gender.
Plan:
- Initiate chemotherapy with R-CHOP regimen.
- Educate patient on potential side effects and symptom management.
- Schedule follow-up appointments for monitoring response to treatment.
Treatment & Plan Section for ICD-10 Code C83.18 – Mantle cell lymphoma, lymph nodes of multiple sites
- First-line treatment includes R-CHOP chemotherapy.
- Consider targeted therapy with ibrutinib for relapsed cases.
- Monitor blood counts and manage side effects proactively.
- Provide nutritional support and psychosocial counseling.
Using ICD-10 Code C83.18 for Mantle cell lymphoma, lymph nodes of multiple sites in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
- Use C83.18 for billing when diagnosing mantle cell lymphoma affecting multiple lymph nodes.
- Align treatment plans with clinical guidelines to support justified billing.
- Document any complications or comorbidities that may affect treatment.
Related ICD-10 Codes Often Used with Mantle cell lymphoma, lymph nodes of multiple sites
- C83.19 – Mantle cell lymphoma, unspecified site
- C82.89 – Other specified types of follicular lymphoma
- C83.30 – Diffuse large B-cell lymphoma, lymph nodes of multiple sites
ICD-10 Code C83.18 in Medical Billing and Insurance for Mantle cell lymphoma, lymph nodes of multiple sites
ICD-10 Code C83.18 is essential for accurate billing in hospital and outpatient settings, particularly in oncology and infectious disease care.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
- Use C83.18 in conjunction with other codes for comorbidities or complications.
- Ensure that the diagnosis is clearly linked to the treatment provided.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 36415 | Collection of venous blood by venipuncture. |
| 99214 | Established patient office visit, moderate complexity. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.18 for Mantle cell lymphoma, lymph nodes of multiple sites
What are the common symptoms of mantle cell lymphoma?
Common symptoms include painless swelling of lymph nodes, unexplained weight loss, night sweats, and fatigue. Patients may also experience abdominal pain if the gastrointestinal tract is involved.
How is mantle cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes. Immunophenotyping and genetic testing may also be performed to confirm the diagnosis.
What treatments are available for mantle cell lymphoma?
Treatment options include chemotherapy regimens such as R-CHOP, targeted therapies like ibrutinib, and stem cell transplantation in eligible patients. Supportive care is also crucial for managing symptoms.
Is mantle cell lymphoma curable?
Mantle cell lymphoma is generally considered an aggressive disease with a poor prognosis. While some patients may achieve remission, it is often challenging to cure, and ongoing management is typically required.
